Results 1 to 10 of about 62,561 (290)

The Benefits of Advanced Botulinum Neurotoxin Injection Training from a Spasticity Management Fellowship [PDF]

open access: yesToxins
Objective: Residency programs in the United States lack the necessary training for physicians to confidently and competently inject botulinum neurotoxin (BoNT) and manage complex spasticity patients. This creates an unmet need for spasticity patients who
John McGuire   +5 more
doaj   +2 more sources

Spasticity in Prolonged Disorders of Consciousness: A Prospective Cohort Study [PDF]

open access: yesBrain Sciences
Background: Spasticity is a frequent and disabling complication in patients with prolonged disorders of consciousness (PDOC), yet its prevalence, distribution, evolution, and relationship with recovery of consciousness remain poorly characterized.
Nathalie Draulans   +6 more
doaj   +2 more sources

Canadian Physicians’ Use of Intramuscular Botulinum Toxin Injections for Shoulder Spasticity: A National Cross-Sectional Survey

open access: yesToxins, 2023
Spasticity of the upper extremity can result in severe pain, along with many complications that can impair a patient’s activities of daily living. Failure to treat patients with spasticity of the upper limb can result in a decrease in the range of motion
Farris Kassam   +6 more
doaj   +1 more source

Ischemic Stroke in a 29-Year-Old Patient with COVID-19: A Case Report

open access: yesCase Reports in Neurology, 2021
Increasing evidence reports a greater incidence of stroke among patients with Coronavirus disease 2019 (COVID-19) than the non-COVID-19 population and suggests that SARS-CoV-2 infection represents a risk factor for thromboembolic and acute ischemic ...
Christian Avvantaggiato   +11 more
doaj   +1 more source

Surgical Approaches to Upper Limb Spasticity in Adult Patients: A Literature Review

open access: yesFrontiers in Rehabilitation Sciences, 2021
Introduction: Spasticity is the main complication of many upper motor neuron disorders. Many studies describe neuro-orthopedic surgeries for the correction of joint and limb deformities due to spasticity, though less in the upper extremity.
Mahdis Hashemi   +9 more
doaj   +1 more source

A Novel Approach to New-Onset Hemiplegic Shoulder Pain With Decreased Range of Motion Using Targeted Diagnostic Nerve Blocks: The ViVe Algorithm

open access: yesFrontiers in Neurology, 2021
Introduction: Hemiplegic shoulder pain (HSP) is the most common pain disorder after stroke with incidence estimates of 30–70% and associated with reductions in function, interference with rehabilitation, and a reduced quality of life.
John W. Fitterer   +4 more
doaj   +1 more source

Canadian Physicians' Use of Perioperative Botulinum Toxin Injections to Spastic Limbs: A Cross-sectional National Survey

open access: yesArchives of Rehabilitation Research and Clinical Translation, 2021
Objective: To investigate the practice patterns of Canadian physicians who use perioperative botulinum toxin (BoNT) injections to improve surgical outcomes on spastic limbs. Design: A cross-sectional national survey composed of an invitation email and an
Farris Kassam, BSc   +4 more
doaj   +1 more source

Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis

open access: yesToxins, 2022
Background: The present study aimed to evaluate the reasons and determinants of BoNT-A discontinuation in patients with stroke, multiple sclerosis, spinal cord injury, and traumatic brain injury.
Nicoletta Cinone   +7 more
doaj   +1 more source

Rehabilitation interventions for glioma patients: a mini-review

open access: yesFrontiers in Surgery, 2023
Glioma is a group of tumors that originate from glial cells within the central nervous system and comprise 27% of all tumors and 80% of malignant tumors.
Stefania Spina   +6 more
doaj   +1 more source

High Doses of Botulinum Toxin Type A for the Treatment of Post-Stroke Spasticity: Rationale for a Real Benefit for the Patients

open access: yesToxins, 2022
In the past few years, there was a great interest in the use of higher doses of botulinum toxin type A, especially in case of upper and lower limb severe spasticity. To date, only one prospective, non-randomized, single-arm, multicenter, open-label, dose-
Andrea Santamato
doaj   +1 more source

Home - About - Disclaimer - Privacy